R&D

Ochre Bio and Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease

Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs), such as late-stage metabolic dysfunction-associated...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Beckman Coulter’s DxI 9000 Immunoassay Analyzer extends menu with new CE-marked hepatitis assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases...

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Approvals

Manufacturiung

Finance

Research & Development
Latest

R&D

Ochre Bio and Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease

Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs),...
R&D

Evotec and Variant Bio to discover and develop fibrosis treatments

Evotec and Variant Bio have announced a collaboration agreement to identify a best-in-class treatment for diseases caused by fibrosis. Fibrosis is characterised by marked and...
R&D

Takeda, Astellas and Sumitomo Mitsui Banking to establish joint venture company for incubation of early drug discovery programs

Takeda, Astellas, and Sumitomo Mitsui Banking Corporation (SMBC) have signed a master agreement to establish a joint venture company. The new company will be...
R&D

Lexeo Therapeutics granted FDA Fast Track designation for Friedreich’s ataxia cardiomyopathy treatment

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to LX2006, Lexeo Therapeutics’ AAVrh.10hFXN-based gene therapy candidate for the treatment of...
R&D

Medincell enters into agreement with AbbVie to develop next-generation long-acting injectable therapies

Medincell has formed a collaboration with AbbVie to co-develop and commercialize up to six therapeutic products across multiple therapeutic areas and indications. It will use...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks